Blog - Litchlab

EN

CN

{$ImageUrl,alt}

Blog

Home>Blog

Comprehensive Analysis of Liposome Types: Diversified Solutions for Vaccine Delivery

Comprehensive Analysis of Liposome Types: Diversified Solutions for Vaccine DeliveryLiposomes, as crucial carriers for vaccine delivery, possess unique structural and functional characteristics that enable them to meet the complex needs of various vaccines. Fr...

Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma

Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma In May 2024, the U.S. Food and Drug Administration (FDA) announced the approval of irinotecan lipos...

mRNA Vaccines and Lipid Nanoparticle Lyophilization Technology: Breakthroughs in Innovative Delivery Systems in Vaccine Development

mRNA Vaccines and Lipid Nanoparticle Lyophilization Technology: Breakthroughs in Innovative Delivery Systems in Vaccine Development Driven by the COVID-19 pandemic, mRNA vaccines and lipid nanoparticle (LNP) delivery systems have become key technologies i...

Litchlab Advances Next-Generation Drug Delivery Technologies, Driving Precision Medicine Forward

Breakthrough Drug Delivery Systems Accelerating Therapeutic InnovationAs RNA therapeutics, tumor immunotherapy, and vaccine development advance rapidly, next-generation drug delivery technologies are playing a crucial role in enhancing bioavailability, targeti...

640 (7).png

Precisely Engineered Albumin-Based Drug Delivery: Litchlab’s Innovation in Targeted Therapy

Breakthrough in Albumin-Drug Conjugates: Advancing Precision MedicineA recent study by Tsinghua University’s School of Pharmaceutical Sciences has introduced a novel albumin-fluorometholone (Alb-FM) conjugate, capable of targeting pancreatic stellate cells (PS...

640 (1).jpg

Precisely Controlled Gold Nanoparticle Surface Engineering: Empowering Targeted Drug Delivery with Litchlab

In the era of precision medicine, the controllability and targeting efficiency of drug delivery systems play a crucial role in determining therapeutic outcomes. Among various nanomaterials, gold nanoparticles (AuNPs) have emerged as a powerful platform for can...

640 (6).png

Supercritical Nanotechnology & Liposomal Drug Delivery: Driving Litchlab’s Innovations in Nanomedicine

Global pharmaceutical leader AstraZeneca has recently announced a licensing agreement with Nanoform, a Finland-based pharmaceutical technology company, to integrate supercritical fluid (SCF) nanotechnology for drug crystallization and optimization at the nanos...

Litchlab’s Gold Nanoparticle Drug Delivery Technology: Advancing Precision Medicine

Gold nanoparticles (AuNPs) are revolutionizing drug delivery with their unique physicochemical properties, high biocompatibility, and tunable surface functionality. As a leader in nanomedicine innovation, Litchlab has developed an advanced gold nanoparticle-ba...

640 (5).png

Litchlab: Advancing Precision Medicine with Gold Nanoparticle (AuNP) Drug Delivery Technology

Gold Nanoparticles (AuNPs): A Next-Generation Drug Delivery Platform Gold nanoparticles (AuNPs) have emerged as a promising drug delivery platform due to their high biocompatibility, tunable surface chemistry, and unique optical and electronic properties. Thes...

上一页 4 5 6 7 8 下一页